Matt Clarke is the CEO of Clarke Consulting, a role held since February 1997, and has extensive experience as a consultant for various pharmaceutical companies, including Sunesis Pharmaceuticals, Theravance, and Five Prime Therapeutics. Clarke's consulting work spans multiple organizations from 1997 to the present, including industry leaders such as Metabolex and Amarin Corporation. Clarke's educational background includes a Bachelor of Science degree in Symbolic Systems from Stanford University, earned between September 1991 and June 1995.
Sign up to view 0 direct reports
Get started